Advertisement

Topics

Alder Biopharmaceuticals Inc. Company Profile

16:39 EDT 25th September 2017 | BioPortfolio

Alder is revolutionizing the way antibody therapies are identified, selected, developed and produced. Our proprietary technologies make great strides possible in the field of antibody therapeutics, dramatically accelerating the way pharmaceutical and biotechnology companies bring new therapies to market.

Location

11804 North Creek Parkway South
Bothell
Washington
98011
United States of America

Contact

Phone: 425-205-2900
Fax: 425-205-2901

Email: info@alderbio.com


News Articles [163 Associated News Articles listed on BioPortfolio]

Alder BioPharmaceuticals (ALDR) versus Raptor Pharmaceutical Corp (RPTP) Head to Head Comparison

Alder BioPharmaceuticals and Raptor Pharmaceutical Corp are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recomm...

Alder shares slump despite migraine success

Alder BioPharmaceuticals announced that its migraine drug eptinezumab succeeded in a late-stage trial for migraine – but shares immediately fell as investors raised concerns about a strong placebo ...

Alder BioPharmaceuticals Announces Positive Eptinezumab Phase 3 Results for Prevention of Frequent Episodic Migraine

BOTHELL, Wash., June 27, 2017 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc., (NASDAQ:ALDR) today announced that eptinezumab, its lead product candidate for migraine prevention, met the primary an...

Fewer headaches, but Phase III data for Alder's biologic fail to impress

USA-based drug developer Alder BioPharmaceuticals has lost a quarter of its share price after announcing…

Alder Biopharmaceuticals Announces Positive Phase 3 Results for Frequent Episodic Migraine Treatment

NewsThe observed safety profile in this study to date was similar to placebo.Contributed Author: 

Alder's shares tumble as migraine drug data disappoints

(Reuters) - Alder BioPharmaceuticals Inc's late-stage study data on its experimental treatment to prevent episodic migraine fell short of investors' expectation, sending its shares plunging as much as...

Alder's migraine drug data disappoints, shares tumble

(Reuters) - Alder BioPharmaceuticals Inc's late-stage study data on its experimental treatment to prevent episodic migraine fell short of investor expectation, sending its shares about 20 percent in p...

Alder Biopharmaceuticals: The Worst Is Yet To Come For Shareholders

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Thrombin human [Ethicon, Inc]

These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...

PubMed Articles [124 Associated PubMed Articles listed on BioPortfolio]

Current practice of therapeutic drug monitoring of biopharmaceuticals in psoriasis patients.

The high prevalence of psoriasis and the high spending on pharmaceuticals motivate a more evidence-based and cost-effective usage of biopharmaceuticals. A growing body of evidence exists that the impl...

Biopharmaceuticals: reference products and biosimilars to treat inflammatory diseases.

Biopharmaceuticals are primarily therapeutic proteins developed to perform specific functions by acting on the disease pathophysiology. Compared to low molecular chemically synthesized drugs, producti...

Double-Diels-Alder Approach to Maoecrystal V. Unexpected C-C Bond-Forming Fragmentations of the 2.2.2-Bicyclic Core.

Synthetic studies toward maoecrystal V are reported. An oxidative dearomatization/Diels-Alder cascade to assemble the natural product carbocyclic core in one step is proposed. A facile electrocyclizat...

Quantifying possible routes for SpnF-catalyzed formal Diels-Alder cycloaddition.

The Diels-Alder reaction is a cornerstone of modern organic synthesis. Despite this, it remains essentially inaccessible to biosynthetic approaches. Only a few natural enzymes catalyze even a formal [...

Catalytic Asymmetric Total Synthesis of (+)- and (-)-Paeoveitol via a Hetero-Diels-Alder Reaction.

The first catalytic asymmetric total synthesis of (+)- and (-)-paeoveitol has been accomplished in 42% overall yield via a biomimetic hetero-Diels-Alder reaction. The chiral phosphoric acid catalyzed ...

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Allergen-specific immunotherapy (SIT), the administration of gradually increasing quantities of an allergen extract to an allergic patient, is a curative approach which directly treats the...

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen

Tree MATA (modified pollen allergen tyrosine adsorbate) has been developed to provide pre-seasonal specific immunotherapy for patients with hypersensitivity to tree (birch, alder, and haze...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen

Allergen-specific immunotherapy (SIT), the administration of gradually increasing quantities of an allergen extract to an allergic patient, is a curative approach which directly treats the...

Companies [184 Associated Companies listed on BioPortfolio]

Alder Biopharmaceuticals Inc.

Alder is revolutionizing the way antibody therapies are identified, selected, developed and produced. Our proprietary technologies make great strides possible in the field of antibody therapeutics, dr...

Herbruck Alder

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=93381

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...

Bechtel Group Biopharmaceuticals Production

Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organiza...

BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercializat...

More Information about "Alder Biopharmaceuticals Inc." on BioPortfolio

We have published hundreds of Alder Biopharmaceuticals Inc. news stories on BioPortfolio along with dozens of Alder Biopharmaceuticals Inc. Clinical Trials and PubMed Articles about Alder Biopharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alder Biopharmaceuticals Inc. Companies in our database. You can also find out about relevant Alder Biopharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record